Ticker Symbol: ENOB
Enochian Biosciences Inc
$10.76 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001527728
Company Profile
Enochian BioSciences is a biopharmaceutical company dedicated to identifying, developing, manufacturing, and commercializing gene-modified cell therapy. Our gene-modified cell therapy platform can be applied to multiple indications including HIV/AIDS, HBV and Oncology.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Century City Medical Plaza
Website: enochianbio.com
CEO: Eric Leire
Tags:
- Finance
- Financial Conglomerates
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $0.70 - $0.75
Beta: 1.38
52wk. High: $2.99
52wk. Low: $0.39
Ytd. Change -32.04%
50 Day Moving Average: $0.56
200 Day Moving Average: $0.93
Shares Outstanding: 58283591
Valuation
Market Cap: 4.1B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A